| 製品名 | Pioglitazone |
|---|---|
| CAS番号 | 111025-46-8 |
| 分子式 | C19H20N2O3S |
| 分子量 | 356.44 |
| 外観 | 白色からオフホワイトの結晶性粉末 |
| 分析(HPLC) | ≥98% |
| 乾燥減量 | ≤0.5% |
| 焼失残渣 | ≤0.1% |
| 重金属 | 10 ppm以下 |
| 融点 | 183-186°C |
| 比回転 | N/A (racemic) |
お困りですか? 弊社チームまでお問い合わせください

同義語
Pioglitazone is a thiazolidinedione that has been a cornerstone in type 2 diabetes management for over two decades. It works by targeting PPAR-γ, a nuclear receptor that directly influences insulin sensitivity in adipose tissue, muscle, and liver. Unlike many other antidiabetic drugs that merely stimulate insulin release, pioglitazone addresses the root issue—insulin resistance—helping patients achieve better long-term glycemic control.
For manufacturers, pioglitazone remains a reliable, cost-effective API with a well-established safety profile. We supply pioglitazone as a high-purity crystalline powder, every batch shipped with a full COA, and we offer flexible packaging from 1 kg trial orders to bulk container shipments. Our global logistics network ensures timely delivery to any destination.
Room,5-0203, Courtyard 205, Lianhu District,Xi'an,Shaanxi,China